iNGEN CRO
Business Services · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
456 St Kilda Rd, Melbourne, Victoria, 30...Website
www.ingenucro.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About iNGEN CRO
iNGENū CRO is a leading clinical research organization based in Australia, specializing in high-quality, FDA-compliant research for innovative biotech firms. They offer expertise in various clinical specialties, including early-stage clinical trials, oncology, and neurology, among others. With a mission to provide cost-effective clinical research services, iNGENū CRO aims to facilitate global access to innovative treatments. Their combination of local expertise and global reach positions them as a trusted partner for biotech companies seeking to navigate the complexities of clinical trials.Explore more
Popular SearchesiNGEN CROiNGENu CROiNGENū CROSIC Code 87,873NAICS Code 54,541Show moreiNGEN CRO Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is iNGEN CRO your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if iNGEN CRO had a recent Job posting/layoffs
Funding: Get notified immidiatlly once iNGEN CRO has new funding data
Website visits: Recent activity has been detected on your website
Check out if iNGEN CRO is spiking on competitors!
Earning: See what the market has to say on iNGEN CRO recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at iNGEN CRO
iNGEN CRO, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when iNGEN CRO launches new products
Check if iNGEN CRO has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined iNGEN CRO as Masked Content
Find more new buyers
Compare Similar Companies to iNGEN CRO
Compare insights from companies similar to iNGEN CRO, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
iNGEN CRO is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
iNGEN CRO is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about iNGEN CRO.
iNGEN CRO Tech Stack
A closer look at the technologies used by iNGEN CRO
iNGEN CRO News & Media
Dr. Sud Agarwal Leads iNGENu CRO in Launching Groundbreaking Clinical Trials for Sleep Disorders Following Ethics Approval
iNGENū CRO, a specialist Contract Research Organization with deep expertise in the complex field of sleep medicine, is pleased to announce that two clinical trials targeting rare and debilitating sleep disorders—Idiopathic Hypersomnia and Narcolepsy—have received ethics approval and are now actively enrolling patients. These pivotal studies are being spearheaded by Dr. Sud Agarwal, Specialist Anaesthesiologist and Clinical Research Physician at iNGENū CRO. iNGENū CRO, a specialist Contract ReseaPsyence Group's NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc ("Psyence Group") (CSE: PSYG), a life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing, is pleased to announce that its NASDAQ listed associate, Psyence Biomedical Ltd (NASDAQ: PBM) ("PBM" or "Psyence Biomed"), has announced that its Australian subsidiary, Psyence Australia Pty Ltd ("Psyence Australia"), has entered into a partnership with Fluence, a global leader in professPsyence Biomed Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd (Nasdaq:PBM) (“Psyence Biomed” or the “Company”) today announced that its Australian subsidiary, Psyence Australia Pty Ltd. (“Psyence Australia”), has entered into a partnership with Fluence, a global leader in professional education and training for psychedelic therapy research, and iNGENū CRO Pty Ltd (“iNGENū”), an Australian clinical research organization (CRO), to support an upcoming Phase llb clinical trial. The trial will
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding iNGEN CRO
Sign Up For FreeTo access detailed company insights
iNGENū CRO is a leading clinical research organization based in Australia, specializing in high-quality, FDA-compliant research for innovative biotech firms. They offer expertise in various clinical specialties, including early-stage clinical trials, oncology, and neurology, among others. With a mission to provide cost-effective clinical research s... Read More
